Toronto Region Research Alliance

Why do health care companies choose Toronto Region for their commercial operations? Chemist Edward B. Shuttleworth established Canada’s first major pharmaceutical operation in Toronto in 1879. From these early beginnings, the Toronto Region is now one of the largest pharmaceutical and biotechnology clusters in North America. Twenty-five of the top 50 global pharmaceutical companies have Canadian headquarters in the Toronto Region.

Written byToronto Region Research Alliance
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Chemist Edward B. Shuttleworth established Canada’s first major pharmaceutical operation in Toronto in 1879. From these early beginnings, the Toronto Region is now one of the largest pharmaceutical and biotechnology clusters in North America. Twenty-five of the top 50 global pharmaceutical companies have Canadian headquarters in the Toronto Region. Dozens of medium and small companies are located in the region.

Why choose the Toronto Region? The reason is simple – the specialized expertise and services to run commercial operations are right here.

In addition to an experienced workforce of close to 40,000 people, there are more than 170 companies that provide specialized services for the health care, pharmaceutical and biotechnology sectors. All the essential functions are here: research, clinical, manufacturing, sales and sales operations, marketing and market research, supply chain management, regulatory, and market access.

Contract research Sixty contract or clinical research organizations (CROs) are located in the Toronto Region. ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Illustration of a developing fetus surrounded by a clear fluid with a subtle yellow tinge, representing amniotic fluid.
January 2026

What Is the Amniotic Fluid Composed of?

The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies

Parse Logo

Parse Biosciences and Graph Therapeutics Partner to Build Large Functional Immune Perturbation Atlas

Sino Biological Logo

Sino Biological's Launch of SwiftFluo® TR-FRET Kits Pioneers a New Era in High-Throughout Kinase Inhibitor Screening

SPT Labtech Logo

SPT Labtech enables automated Twist Bioscience NGS library preparation workflows on SPT's firefly platform